CNNA (Cann American) EBIT: $-1.80 Mil (TTM As of Aug. 2012)


What is Cann American EBIT?

Cann American CNNA EBIT is $-1.80 Mil as of Aug. 2012.

Cann American's earnings before interest and taxes (EBIT) for the three months ended in Aug. 2012 was $-0.09 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Aug. 2012 was $-1.80 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Cann American's annualized ROC % for the quarter that ended in Aug. 2012 was -28.77%. Cann American's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2012 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Cann American's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Aug. 2012 was -180.78%.


Cann American  (OTCPK:CNNA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Cann American's annualized ROC % for the quarter that ended in Aug. 2012 is calculated as:

ROC % (Q: Aug. 2012 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: May. 2012 ) + Invested Capital (Q: Aug. 2012 ))/ count )
=-0.352 * ( 1 - % )/( (1.354 + 1.093)/ 2 )
=-0.352/1.2235
=-28.77 %

where

Note: The Operating Income data used here is four times the quarterly (Aug. 2012) data.

2. Joel Greenblatt's definition of Return on Capital:

Cann American's annualized ROC (Joel Greenblatt) % for the quarter that ended in Aug. 2012 is calculated as:

ROC (Joel Greenblatt) %(Q: Aug. 2012 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: May. 2012  Q: Aug. 2012
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-0.352/( ( (0 + max(-0.045, 0)) + (0 + max(-0.1, 0)) )/ 2 )
=-0.352/( ( 0 + 0 )/ 2 )
=-0.352/0
= %

where Working Capital is:

Working Capital(Q: May. 2012 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.007) - (0.052 + 0 + 0)
=-0.045

Working Capital(Q: Aug. 2012 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0.005) - (0.105 + 0 + 5.5511151231258E-17)
=-0.1

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Aug. 2012) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Cann American's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Aug. 2012 )
=-1.797/0.994
=-180.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cann American EBIT Related Terms


Cann American EBIT Historical Data

* Premium members only.

The historical data trend for Cann American's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cann American EBIT Chart

Cann American Annual Data
Trend Feb08 Feb09 Feb10 Feb11 Feb12
EBIT
-0.01 -0.05 -0.01 -0.27 -1.65

Cann American Quarterly Data
Nov07 Feb08 May08 Aug08 Nov08 Feb09 May09 Aug09 Nov09 Feb10 May10 Aug10 Nov10 Feb11 May11 Aug11 Nov11 Feb12 May12 Aug12
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.21 -0.90 -0.60 -0.21 -0.09

CNNA vs GLUC, HISP, FTLF: EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cann American's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cann American EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cann American's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cann American's EV-to-EBIT falls into.



Cann American EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Aug. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-1.80 Mil mean?
Cann American (CNNA) has a EBIT of $-1.80 Mil as of Aug. 2012. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cann American.
Is Cann American's EBIT too high?
Cann American's current EBIT is $-1.80 Mil.
How does Cann American's EBIT compare to GLUC and HISP?
Cann American's EBIT of $-1.80 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Drug Manufacturers company?
A good EBIT depends on the Drug Manufacturers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Cann American. Cann American's current EBIT is $-1.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cann American stock overvalued right now?
Cann American (CNNA) has a current EBIT of $-1.80 Mil. The current EBIT is $-1.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Cann American (CNNA), the current EBIT is $-1.80 Mil as of Aug. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cann American Business Description

Address 320 Santana Drive, Suite C, Cloverdale, CA, USA, 95425
Cann American Corp is engaged in developing assets in legal cannabis and hemp industries. It is focused on consulting, infrastructure developming assets, product marketing and strategic acquisitions within the legal cannabis and hemp industries.